D-0324-2024 Class II Terminated

Recalled by The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories — La Vergne, TN

Recall Details

Product Type
Drugs
Report Date
February 21, 2024
Initiation Date
February 9, 2024
Termination Date
December 22, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
8,198 units

Product Description

HydrALAZINE Hydrochloride Tablets, USP 10mg, packaged in 100-count (10x10 blister cards), Lot T04680, Rx only, Manufactured for Heritage Pharmaceuticals, Inc. Eatontown, NJ, Distributed by Major Pharmaceuticals Livonia MI. NDC 0904-6440-61

Reason for Recall

an out of specification result obtained during routine stability testing for Impurities. There is a remote possibility that use of this product could cause a medically reversible or transient adverse health consequences.

Distribution Pattern

The product was distributed nationwide within the United States.

Code Information

Lot #: T04680, Exp. Date 6/2024